Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Bitterman

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|October 1, 1982
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterizationP B Bitterman, S I Rennard, G W Hunninghake, et al.
The American Review of Respiratory Disease|January 1, 1988
Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disordersS I Rennard, P B Bitterman, T Ozaki, et al.
American Journal of Clinical Pathology|May 1, 1992
Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavageM W Stanley, M J Henry-Stanley, K J Gajl-Peczalska, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 1999
Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disordersA Tan, H Levrey, C Dahm, et al.
The American Review of Respiratory Disease|December 1, 1987
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dustsW N Rom, P B Bitterman, S I Rennard, et al.
Medicine|September 1, 1989
Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literatureM I Hertz, J A Englund, D Snover, et al.
The American Review of Respiratory Disease|September 1, 1984
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factorJ G Lacronique, S I Rennard, P B Bitterman, et al.
The Journal of Laboratory and Clinical Medicine|July 31, 2001
Inhibition of mesothelioma cell growth in vitro by doxycyclineJ B Rubins, D Charboneau, M D Alter, et al.
The Journal of Clinical Investigation|March 1, 1986
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediatorsP B Bitterman, M D Wewers, S I Rennard, et al.
The Journal of Clinical Investigation|August 1, 1984
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lungP B Bitterman, L E Saltzman, S Adelberg, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|October 1, 1982
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterizationP B Bitterman, S I Rennard, G W Hunninghake, et al.
The American Review of Respiratory Disease|January 1, 1988
Colchicine suppresses the release of fibroblast growth factors from alveolar macrophages in vitro. The basis of a possible therapeutic approach ot the fibrotic disordersS I Rennard, P B Bitterman, T Ozaki, et al.
American Journal of Clinical Pathology|May 1, 1992
Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavageM W Stanley, M J Henry-Stanley, K J Gajl-Peczalska, et al.
American Journal of Respiratory and Critical Care Medicine|January 5, 1999
Lovastatin induces fibroblast apoptosis in vitro and in vivo. A possible therapy for fibroproliferative disordersA Tan, H Levrey, C Dahm, et al.
The American Review of Respiratory Disease|December 1, 1987
Characterization of the lower respiratory tract inflammation of nonsmoking individuals with interstitial lung disease associated with chronic inhalation of inorganic dustsW N Rom, P B Bitterman, S I Rennard, et al.
Medicine|September 1, 1989
Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literatureM I Hertz, J A Englund, D Snover, et al.
The American Review of Respiratory Disease|September 1, 1984
Alveolar macrophages in idiopathic pulmonary fibrosis have glucocorticoid receptors, but glucocorticoid therapy does not suppress alveolar macrophage release of fibronectin and alveolar macrophage derived growth factorJ G Lacronique, S I Rennard, P B Bitterman, et al.
The Journal of Laboratory and Clinical Medicine|July 31, 2001
Inhibition of mesothelioma cell growth in vitro by doxycyclineJ B Rubins, D Charboneau, M D Alter, et al.
The Journal of Clinical Investigation|March 1, 1986
Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediatorsP B Bitterman, M D Wewers, S I Rennard, et al.
The Journal of Clinical Investigation|August 1, 1984
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lungP B Bitterman, L E Saltzman, S Adelberg, et al.
Pageof 6